BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim M, Lee Y, Yoon JS, Lee M, Kye SS, Kim SW, Cho Y. The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Cancers (Basel) 2021;13:2301. [PMID: 34064988 DOI: 10.3390/cancers13102301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Su C, Yang Q. Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease. Front Pharmacol 2022;13:1032789. [PMID: 36588741 DOI: 10.3389/fphar.2022.1032789] [Reference Citation Analysis]
2 Liu K, Huang Z, Yang S, Lin L, Zheng S, Zhang X, Xue Y, Xie W. The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis. J Hepatocell Carcinoma 2022;9:1057-63. [PMID: 36250136 DOI: 10.2147/JHC.S386977] [Reference Citation Analysis]
3 Han W, Huang C, Ji Y, Zhou L, Chen J, Hou J. Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus. Front Med 2021;8. [DOI: 10.3389/fmed.2021.805029] [Reference Citation Analysis]
4 Han W, Hou J. Letter: cross-linkage between bacterial taxonomy and gene functions-a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2021;54:1505-7. [PMID: 34741331 DOI: 10.1111/apt.16628] [Reference Citation Analysis]